AMH and polycystic ovary syndrome: Hence, we here aimed to: i) compare, in a large series of women, the performances of state-of-the-art LC–MS/MS assays for hyperandrogenemia and of AMH assays for PCOM with those of routine immunoassays and US examinations conducted earlier; and ii) study how the implementation of these techniques would impact the distribution of PCOS phenotypes.